Phospholipase A2 degradation products modulate epithelial and stromal 5α-reductase activity of human benign prostatic hyperplasia in vitro

Prostate

Volumn 50, Issue 1, 2002, Pages 4-14

  Weisser, Heike ^a   Ziemssen, Tjalf ^a   Krieg, Michael ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

5 reductase; Human prostate; Lipid environment; Lysophospholipid; Modulation

Indexed keywords

ALBUMIN; FATTY ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLSERINE; LYSOPHOSPHOLIPID; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A2; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; ALBUMINOID; ENZYME INHIBITOR; PHOSPHOLIPASE A; TESTOSTERONE 5 ALPHA REDUCTASE;

AGED; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; DOSE RESPONSE; DRUG POTENTIATION; ENZYMOLOGY; EPITHELIUM CELL; METABOLISM; PATHOLOGY; STROMA CELL;

AGED; AGED, 80 AND OVER; ALBUMINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; EPITHELIAL CELLS; FATTY ACIDS; HUMAN; LYSOPHOSPHOLIPIDS; MALE; PHOSPHOLIPASES A; PROSTATIC HYPERPLASIA; STROMAL CELLS; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0036006754     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10027     Document Type: Article

References (45)

1. New concepts in studying the control of normal and cancer growth of the prostate
2. Androgens and human benign prostatic hyperplasia (BPH)
3. Potential activities of androgen metabolizing enzymes in human prostate
4. Kinetic analysis of 5α-reductase isoenzymes in benign prostatic hyperplasia (BPH)
5. Effect of aging on kinetic parameters of 5α-reductase in epithelium and stroma of normal and hyperplastic human prostate
6. Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases
7. Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism
8. Steroid 5α-reductase: Two genes/two enzymes
9. Characterization of Chinese hamster ovary cell lines expressing human steroid 5α-reductase isozymes
10. Benign prostatic hyperplasia and normal prostate aging: Differences in types I and II 5α-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels
11. Characterization of 5α-reductase gene expression in stroma and epithelium of human prostate
12. 5α-reductase inhibition by finasteride (Proscar®) in epithelium and stroma of human benign prostatic hyperplasia
13. Kinetic analysis of androstenedione 5α-reductase in epithelium and stroma of human prostate
14. Partial purification of human prostatic 5α-reductase (3-oxo-5α-steroid:NADP + 4-ene-oxido-reductase; EC 1.3.1.22) in a stable and active form
15. Lipid composition in epithelium and stroma of human benign prostatic hyperplasia
16. Fatty acid composition of phospholipids in epithelium and stroma of human benign prostatic hyperplasia
17. 4-steroid 5α-reductase activity in vitro by the phospholipid environment
18. Phospholipid requirement of epididymal testosterone 5α-reductase and phospholipid composition of epididymal microsomes
19. In vitro modulation of steroid 5α-reductase activity by phospholipases in epithelium and stroma of human benign prostatic hyperplasia
20. Effects of Sabal serrulata extract and its subfractions on 5α-reductase in human benign prostatic hyperplasia
21. Inhibition of steroid 5α-reductase activity by aliphatic fatty acids. Candidates for chemoprevention of prostate cancer
22. Inhibition of steroid 5α-reductase by specific aliphatic unsaturated fatty acids
23. 2+-stimulated ATPase activity of sarcoplasmic reticulum
24. 2+-ATPase activity in the sarcoplasmic reticulum
25. Preferential tissue for androgen metabolism and oestrogen binding
26. Effect of aging on kinetic parameters of 3α(β)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate
27. 5α-androstane-3β,17β-diol hydroxylating enzymes in stroma and epithelium of human benign prostatic hyperplasia (BPH)
28. 17β-hydroxysteroid oxidoreductase in epithelium and stroma of human prostate
29. Protein measurement with the folin phenol reagent
30. Saure und alkalische phosphatase in serum (Zwei-Punkt-methode)
31. The determination of enzyme dissociation constants
32. Distribution and concentrations of androgens in epithelial and stromal compartments of the human benign hypertrophic prostate
33. Effect of aging on endogenous level of 5α-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate
34. pH-dependency of 5α-reductase kinetic characteristics in epithelium and stroma of human BPH
35. 2 and phospholipase C on the activity of rat epididymal nuclear and microsomal 4-ene steroid 5α-reductase
36. Properties of 4-ene-5α-reductase and studies on its solubilization from porcine testicular microsomes
37. Purification of testosterone 5α-reductase from human prostate by a four-step chromatographic procedure
38. Phospholipid requirement of progesterone 5α-reductase from gastric mucosa microsomes of guinea pig
39. Some properties of progesterone 5α-reductase solubilized from rat liver microsomes
40. Solubilization of nuclear steroid 5α-reductase from rat ventral prostate
41. Solubilization of human prostatic 5α-reductase
42. Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction
43. 2 in human and bovine reproductive organs
44. The presence of an androgen controlled phospholipase A in rat epididymis
45. 2 activity: pH optima, its cellular and subcellular distribution in the gonade and some factors that may modulate its activity